A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs

Archives of Internal Medicine

Volumn 165, Issue 7, 2005, Pages 808-813

  Gill, Sudeep S ^a,d   Mamdani, Muhammad ^a   Naglie, Gary ^b   Streiner, David L ^c   Bronskill, Susan E ^a   Kopp, Alexander ^a   Shulman, Kenneth I ^a   Lee, Philip E ^c   Rochon, Paula A ^c  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c Kunin Lunenfeld Applied Research Unit and Department of Food and Nutrition Services and Baycrest Centre for Geriatric Care   (Canada)

^d St Mary's of the Lake Hospital   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIPARKINSON AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; DIURETIC AGENT; DONEPEZIL; FLAVOXATE; GALANTAMINE; NEUROLEPTIC AGENT; OXYBUTYNIN; RIVASTIGMINE; TOLTERODINE; TRICYCLIC ANTIDEPRESSANT AGENT;

AGE DISTRIBUTION; AGED; ARTICLE; CANADA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMENTIA; DRUG USE; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; URINE INCONTINENCE;

AGED; AGED, 80 AND OVER; CHOLINERGIC ANTAGONISTS; CHOLINESTERASE INHIBITORS; COHORT STUDIES; DEMENTIA; FEMALE; HUMANS; MALE; MEDICATION ERRORS; POLYPHARMACY; RETROSPECTIVE STUDIES; URINARY INCONTINENCE;

EID: 17644379934     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.165.7.808     Document Type: Article

References (30)

1. Gurwitz JH, Rochon P. Improving the quality of medication use in elderly patients: a not-so-simple prescription. Arch Intern Med. 2002;162:1670-1672.
2. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163:2716-2724.
3. McLeod PJ, Huang AR, Tamblyn RM, Gayton DC. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ. 1997;156:385-391.
4. Soumerai SB, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA. 1997;277:115-121.
5. Rochon PA, Anderson GM, Tu JV, et al. Use of beta-blocker therapy in older patients after acute myocardial infarction in Ontario. CMAJ. 1999;161:1403-1408.
6. McLaughlin TJ, Soumerai SB, Willison DJ, et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med. 1996;156:799-805.
7. Fried LP, Storer DJ, King DE, Lodder F. Diagnosis of illness presentation in the elderly. J Am Geriatr Soc. 1991;39:117-123.
8. Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ. 1997;315:1096-1099.
9. Hashimoto M, Imamura T, Tanimukai S, Kazui H, Mori E. Urinary incontinence: an unrecognised adverse effect with donepezil [letter]. Lancet. 2000;356:568.
10. Hemingway-Eltomey JM, Lerner AJ. Adverse effects of donepezil in treating Alzheimer's disease associated with Down's syndrome [letter]. Am J Psychiatry. 1999;156:1470.
11. Thakar R, Stanton S. Regular review: management of urinary incontinence in women. BMJ. 2000;321:1326-1331.
12. Skelly J, Flint AJ. Urinary incontinence associated with dementia. J Am Geriatr Soc. 1995;43:286-294.
13. Herbison P, Hay-Smith J, Ellis G, Moore K. Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. BMJ. 2003;326:841-844.
14. Donnellan CA, Fook L, McDonald P, Playfer JR. Oxybutynin and cognitive dysfunction. BMJ. 1997;315:1363-1364.
15. Katz IR, Sands LP, Bilker W, DiFilippo S, Boyce A, D'Angelo K. Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride. J Am Geriatr Soc. 1998;46:8-13.
16. Agostini JV, Leo-Summers LS, Inouye SK. Cognitive and other adverse effects of diphenhydramine use in hospitalized older patients. Arch Intern Med. 2001;161:2091-2097.
17. Canadian Pharmacists Association. Compendium of Pharmaceutical and Specialties. 38th ed. Ottawa, Ontario: Canadian Pharmacists Association; 2003.
18. Roe CM, Anderson MJ, Spivack B. How many patients complete an adequate trial of donepezil? Alzheimer Dis Assoc Disord. 2002;16:49-51.
19. Levy AR, O'Brien BJ, Sellors C, Grootendorst P, Willison D. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol. 2003;10:67-71.
20. Laupacis A. Inclusion of drugs in provincial drug benefit programs: who is making these decisions, and are they the right ones? CMAJ. 2002;166:44-47.
21. Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol. 2001;154:854-864.
22. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
23. Roe CM, Anderson MJ, Spivack B. Use of anticholinergic medications by older adults with dementia. J Am Geriatr Soc. 2002;50:836-842.
24. Lu C-J, Tune LE. Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease. Am J Geriatr Psychiatry. 2003;11:458-461.
25. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med. 1998;338:1516-1520.
26. Saskatchewan Formulary Committee. Quarterly update to the 50th edition of the Saskatchewan Formulary, No. 86. 2001. Available at: http://formulary. drugplan.health.gov.sk.ca/FormularyBulletins/Bulletin86Apr2001.pdf. Accessed September 17, 2004.
27. Loannidis JP, Lau J. Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA. 2001;285:437-443.
28. Petri H, de Vet HC, Naus J, Urquhart J. Prescription sequence analysis: a new and fast method for assessing certain adverse reactions of prescription drugs in large populations. Stat Med. 1988;7:1171-1175.
29. Berlowitz DR, Brand HK, Perkins C. Geriatric syndromes as outcome measures of hospital care: can administrative data be used? J Am Geriatr Soc. 1999;47:692-696.
30. Edwards KR, O'Connor JT. Risk of delirium with concomitant use of tolterodine and acetylcholinesterase inhibitors. J Am Geriatr Soc. 2002;50:1165-1166.